QRVO vs QNCX: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

QRVO has stronger fundamentals based on our AI analysis.

QRVO
Qorvo, Inc.
BUY
72%
Confidence
VS
QNCX
Quince Therapeutics, Inc.
STRONG SELL
97%
Confidence

QRVO vs QNCX Fundamental Comparison

Metric QRVO QNCX
Revenue $2.9B N/A
Net Income $309.3M $-84.0M
Net Margin 10.8% N/A
ROE 8.4% N/A
ROA 5.0% -89.8%
Current Ratio 3.67x 0.53x
Debt/Equity 0.42x N/A
EPS $3.30 $-1.68

Green = Better metric | Red = Weaker metric

View Full QRVO Analysis →
View Full QNCX Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

QRVO vs AAPL QNCX vs MSFT QRVO vs GOOGL QNCX vs AMZN

QRVO vs QNCX: Frequently Asked Questions

Is QRVO or QNCX a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), QRVO has stronger fundamentals. QRVO is rated BUY (72% confidence) while QNCX is rated STRONG SELL (97% confidence). This is not investment advice.

How does QRVO compare to QNCX fundamentally?

Qorvo, Inc. has ROE of 8.4% vs Quince Therapeutics, Inc.'s N/A. Net margins are 10.8% vs N/A respectively.

Which stock pays higher dividends, QRVO or QNCX?

QRVO has a dividend yield of N/A or no dividend while QNCX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in QRVO or QNCX for long term?

For long-term investing, consider that QRVO has BUY rating with 72% confidence, while QNCX has STRONG SELL rating with 97% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about QRVO vs QNCX?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For QRVO vs QNCX, the AI consensus favors QRVO based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.